feng lin

Feng Lin, MS

  • Corporate Affiliate Visiting Fellow, 2014-15

Biography

Feng Lin is a corporate affiliate visiting fellow at the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) for 2014-15.  Lin is the founder and chairman of ACON Biotechnology Group, which built the first GMP IVD facility and the first US FDA IVD facility registered in China.  Lin has also invested in the leading clinical laboratories in China and a leading life sciences and drug discoveries company in the U.S.  While at Stanford, Lin is researching the innovations in China Primary Healthcare Reform.  He holds a master's degree in Chemical Engineering from Oklahoma State University.

publications

Journal Articles
October 2015

The innovations in China’s primary health care reform: Development and characteristics of the community health services in Hangzhou

Author(s)
cover link The innovations in China’s primary health care reform: Development and characteristics of the community health services in Hangzhou